Healthcare - Biotechnology - NASDAQ - US
$ 3.38
2.42 %
$ 3.53 M
Market Cap
-0.23
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--50.00%
Net Income
Estimate
8.36%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pasithea Therapeutics Corp.
KTTA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart KTTA
EBIT FORECAST
EBIT Forecast Chart KTTA
NET INCOME FORECAST
Net Income Chart KTTA